Feb 26, 2026 · Veru is focused on the development of enobosarm, a novel, oral, selective androgen receptor modulator (SARM) to address one of the most significant adverse effects, the loss of …

Find the latest Veru Inc. (VERU) stock quote, history, news and other vital information to help you with your stock trading and investing.

3 days ago · VERU | Complete Veru Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

4 days ago · See the latest Veru stock price NASDAQ: VERU stock rating, related news, valuation, dividends and more to help you make your investing decisions.

Feb 11, 2026 · Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases.

4 days ago · View Veru Inc VERU investment & stock information. Get the latest Veru Inc VERU detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Veru’s Phase 2b PLATEAU clinical trial is a double-blind, placebo-controlled study to evaluate the effect of enobosarm 3mg on total body weight, fat mass, lean mass, physical function, bone mineral density …

Get the latest Veru Inc (VERU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

4 days ago · Veru’s Phase 2b PLATEAU clinical trial is a double-blind, placebo-controlled study to evaluate the effect of enobosarm 3mg on total body weight, fat mass, lean mass, physical function, …

View Veru Inc VERU stock quote prices, financial information, real-time forecasts, and company news from CNN.